Loading...

Loading...

Oral Semaglutide Falls Short in Alzheimer’s Study: Novo Nordisk
Oral Semaglutide Falls Short in Alzheimer’s Study: Novo Nordisk
By Sofía Garduño - Mon, 11/24/2025 - 14:24
Novo Nordisk’s phase 3 trials of oral semaglutide in early Alzheimer’s failed to meet primary endpoints.

Featured content

Most popular

https://mexicobusiness.news/tag/alzheimers-disease-0
More Health
Hearing Loss as a Hidden Contributor to Dementia
Hearing Loss as a Hidden Contributor to Dementia
By Aura Moreno - Mon, 05/26/2025 - 09:26
Hearing loss increases dementia risk. Early detection and hearing aids can reduce cognitive decline in millions of Mexicans.
Shingles Vaccine Linked to Lower Dementia Risk
Shingles Vaccine Linked to Lower Dementia Risk
By Sofía Garduño - Wed, 04/02/2025 - 17:00
The shingles vaccine may lower dementia risk, offering potential health benefits beyond preventing the virus, a new study finds.
Study Links Long-Term NSAID Use to Lower Dementia Risk
Study Links Long-Term NSAID Use to Lower Dementia Risk
By Sofía Garduño - Wed, 03/19/2025 - 15:28
A study suggests that the long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce dementia risk by lowering inflammation.
IMSS Highlights Early Alzheimer’s Diagnosis for Better Outcomes
IMSS Highlights Early Alzheimer’s Diagnosis for Better Outcomes
By Sofía Garduño - Wed, 10/09/2024 - 09:30
IMSS highlights the need for early Alzheimer’s detection amid rising memory loss in older adults.